ACROBiosystems  has begun to narrow its focus into helping accelerate the process between preclinical, clinical and commercialization. The new strategic focus has culminated in the investment and emphasis on GMP-grade products and services, alongside the launch of their new ClinMax product line which encompasses preclinical and clinical pathology and technical service platforms. To better meet the needs of their customers for safe, reliable, and high-quality raw materials for clinical manufac...